JIM
GBT

Jupiter Investment Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Jupiter Investment Management’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-18,806
Closed -$298K – 540
2016
Q1 		$298K Buy
+18,806
New +$334K 0.01% 390

Other funds holding GBT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return

Jupiter Investment Management's GBT Position: Q2 2016 in Review

Jupiter Investment Management sold out of Global Blood Therapeutics, Inc. (GBT) in Q2 2016, closing a stake of 18,806 shares — an estimated $298K sold.

Jupiter Investment Management first reported a position in GBT in Q1 2016 and held it in 1 quarter. The position peaked at $298K in Q1 2016. 93 funds tracked by Wall St. Rank hold GBT as of Q2 2016.

  • Jupiter Investment Management reported no remaining Global Blood Therapeutics, Inc. position as of Q2 2016 after selling out during the quarter.
  • Jupiter Investment Management sold 18,806 Global Blood Therapeutics, Inc. shares in Q2 2016, an estimated $298K.
  • Jupiter Investment Management first reported a position in Global Blood Therapeutics, Inc. in Q1 2016 and held it in 1 quarter.
  • Jupiter Investment Management's Global Blood Therapeutics, Inc. position peaked at $298K in Q1 2016.
  • 93 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q2 2016.

Based on Jupiter Investment Management's 13F filing for Q2 2016, filed 22 Jul 2016.